29 September 2025
Explore the benefits of the generic HIV prevention drug lenacapavir, set to change the landscape of global health by 2027.
16 September 2025
Ascendis to delist from the JSE as part of its strategy to go private, aiming for operational freedom and agility.
11 September 2025
5 September 2025
Gilead’s Lenacapavir is set to revolutionise HIV prevention efforts, aiming to protect two million people across affected nations.
4 September 2025
Understand Aspen Unlocking Value efforts as CEO Stephen Saad addresses the decline in share price and targets business improvements.
25 August 2025
Uncover the Global Health Crisis caused by the loss of crucial medicines, risking a resurgence of neglected tropical diseases.
24 August 2025
Aspen Pharmacare shares see a sharp decline on the JSE following an alarming profit warning. What does it mean for investors?
24 August 2025
Adcock Ingram reports steady annual profits as winter demand for Panado and Corenza-C drives growth in the second half.
22 August 2025
Novo Nordisk implements a hiring freeze as layoffs approach after Wegovy's success. Discover the impact on the pharmaceutical industry.
19 August 2025
Regulatory delays are hindering Africa's R1.25-trillion pharmaceutical manufacturing goals and access to markets.
13 August 2025
Health activists highlight the issues with Vertex's Trikafta pricing and access, advocating for justice in cystic fibrosis care.
1 August 2025
Trump demands lower pharmaceutical prices from major drug companies in a bold move to align US costs with global standards.